Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy Women

Lignende værker

• Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses
  af: Rose, Trine Høyer, et al.
  Udgivet: (2016)
• Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
  af: Olsson, Håkan, et al.
  Udgivet: (2015)
• Recombinant FSH glycoforms are bioactive in mouse preantral ovarian follicles
  af: Simon, Leah E., et al.
  Udgivet: (2019)
• Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
  af: Tayyar, Ahter Tanay, et al.
  Udgivet: (2018)
• Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
  af: Younis, Johnny S.
  Udgivet: (2017)